Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr:76:103440.
doi: 10.1016/j.amsu.2022.103440. Epub 2022 Mar 3.

Post COVID-19 neurological complications; a meta-analysis

Affiliations
Review

Post COVID-19 neurological complications; a meta-analysis

Jaafar Omer Ahmed et al. Ann Med Surg (Lond). 2022 Apr.

Abstract

Introduction: Despite numerous studies regarding neurological manifestations and complications of COVID-19, only a few cases of neurological consequences following complete recovery from SARS-CoV-2 infection have been described.

Objectives: The current study aims to present a quantitative meta-analysis of published studies regarding the post-infectious neurological complications of COVID-19.

Data sources: The Web of Science, PubMed, MEDLINE on OVID, and Google scholar were searched for English-language researches published after January 1, 2020.

Result: The review of the literature revealed 60 cases - of which 40 (66.7%) cases were male, and 18 (30%) were female. The average age was 44.95 years. Overall, 17 (28.3%) patients had comorbid conditions. Twenty-four (40%) patients were hospitalized during an active COVID-19 infection. The average interval from the COVID-19 infection to the onset of neurological sequelae was 33.2 days. Guillain-Barre syndrome was the most commonly reported neurological condition (15, 25%).

Conclusion: Despite recovery from acute infection, the pandemic highlights the significance of ongoing, comprehensive follow-up of all COVID-19 patients - even those initially were believed to be asymptomatic.

Keywords: COVID-19; Neurological complication; Post COVID-19 syndrome; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA chart.

References

    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. - PMC - PubMed
    1. Kakamad F.H., Mahmood S.O., Rahim H.M., Abdulla B.A., Abdullah H.O., Othman S., et al. Post covid-19 invasive pulmonary Aspergillosis: a case report. International journal of surgery case reports. 2021;82:105865. - PMC - PubMed
    1. Collantes M.E., Espiritu A.I., Sy M.C., Anlacan V.M., Jamora R.D. Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis. Can. J. Neurol. Sci. 2021;48(1):66–76. - PMC - PubMed
    1. Chen X., Laurent S., Onur O.A., Kleineberg N.N., Fink G.R., Schweitzer F., et al. A systematic review of neurological symptoms and complications of COVID-19. J. Neurol. 2020;268:392–402. - PMC - PubMed
    1. Sriwastava S., Kataria S., Tandon M., Patel J., Patel R., Jowkar A., et al. Guillain Barré Syndrome and its variants as a manifestation of COVID-19: a systematic review of case reports and case series. J. Neurol. Sci. 2021;420:117263. - PMC - PubMed

LinkOut - more resources